Pattern of dermatological manifestations among patients of rheumatic disorders at a tertiary care centre from Kashmir valley in North India

Authors

  • Farah Sameem Department of Venereology and Leprosy, Postgraduate Institute of Dermatology, SKIMS Medical College, Srinagar, Jammu and Kashmir, India
  • Samia Aleem Department of Health and Family Welfare, Jammu and Kashmir, India
  • Sumaiya Majeed Department of Venereology and Leprosy, Postgraduate Institute of Dermatology, SKIMS Medical College, Srinagar, Jammu and Kashmir, India
  • Aaqib Aslam Department of Venereology and Leprosy, Postgraduate Institute of Dermatology, SKIMS Medical College, Srinagar, Jammu and Kashmir, India
  • Seerat Fatima Department of Venereology and Leprosy, Postgraduate Institute of Dermatology, SKIMS Medical College, Srinagar, Jammu and Kashmir, India
  • Sheikh Manzoor Department of Venereology and Leprosy, Postgraduate Institute of Dermatology, SKIMS Medical College, Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20231162

Keywords:

Cutaneous, Rheumatic, Systemic, Diagnosis

Abstract

Background: Various rheumatic disorders have cutaneous manifestations which sometimes precede systemic symptoms. These manifestations, therefore can act as diagnostic and prognostic markers of the rheumatic disorders. Understanding them may lead to early diagnosis, prompt treatment, and hence lower morbidity and mortality of the affected persons. The aims and objectives were to study the pattern of dermatological manifestations among patients of rheumatic disorders at a tertiary care centre from Kashmir valley in North India.

Methods: Prospective observational study carried out in the department of Dermatology at SKIMS medical college in Kashmir valley in north India over a span of 12 months from July 2021 to June 2022. A sample size of 100 native Kashmiri patients of rheumatic disorders presenting to OPD with dermatological manifestations were included in the study. A detailed dermatological examination and history was taken. The various demographic data sought included age, gender, occupation, residence and clinical diagnosis. Each clinical entity was individually studied for specific features.

Results: The mean age of presentation of rheumatic disorders was 33 years with the maximum number of patients (n=61) belonged to the age group of 20-40 years. Females outnumbered males (ratio of 1:2.225). Disorders like lupus and scleroderma were the most common rheumatic entity in this series. Besides these, vasculitis, Behcet’s disease, rheumatic arthritis, psoriatic arthritis and others also have significant cutaneous manifestations.

Conclusions: Some rheumatic disease have significant cutaneous manifestations, understanding of which is essential for their proper management.

References

Loza E, Abasolo L, Jover JA, Carmona L, EISER Study Group. Burden of disease across chronic diseases: a health survey that measured prevalence, function, and quality of life. J Rheumatol. 2008;35(1):159-65.

Lee HJ, Sinha AA. Cutaneous lupus erythematous: understanding of clinical features, genetic basis and pathobiology of disease guides therapeutic strategies. Autoimmunity. 2006;38(6):433-44.

Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P. The spectrum of cutaneous manifestations in lupus erythematosus-the Italian experience. Lupus. 2000;9(6):417-23.

Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-86.

Hoogen F, Khanna D, Fransen J, Johnson SR. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747-55.

Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292(7):344-7.

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580-8.

Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-73.

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-2.

Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69:35-45.

Michet CJ, McKenna CH, Luthra HS, O’Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104(1):74-8.

Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease In: Kasukawa, R, Sharp, G, eds. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier; 1987: 33-40.

International Study Group for Behcets Disease Criteria for diagnosis of Behcet’s disease. International study group for Behcet’s disease. Lancet. 1990;335(8697):1078-80.

Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, et al. Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterization. Ann Rheum Dis. 2010;69(5):790-7.

Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094-100.

Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33(8):1101-7.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, endocarditis and kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110(17):2747-71.

Oguntona SA, Edunjobi AS, Olaatunde AO. Prevalence of rheumatic diseases in rheumatology outpatient practice of a tertiary hospital. Int Res J Med Biomed Sci. 2016;10(6):11-8.

Senna ER, Barros ALPD, Silva EO, Costa IF, Pereira LVB, Ciconelli RM, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31(3):594-7.

Jokar M, Jokar M. Prevalence of Inflammatory Rheumatic Diseases in a Rheumatologic outpatient clinic: analysis of 12626 cases. Rheumatol Res. 2018;3(1):21-2.

Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythomatosus. J Am Acad Dermatol. 1981;4(4):471-5.

Kole AK, Ghosh A. Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center. Indian J Dermatol. 2009;54(2):132-6.

Rasheed A, Rasul S, Hameed A. Prevalence of usual and unusual skin manifestations of systemic lupus erythematosus in a tertiary care hospital. J Pak Assoc Dermatol. 2016;26(2):118-22.

Fernanda G, Letícia E, Eduardo MC, Barreto SM, Thelma LS. Prevalence of cutaneous findings in systemic sclerosis patients: experience of a teaching hospital. Anais Brasileiros de Dermatologia. 2005;80:481-6.

Ghosh SK, Bandyopadhyay D, Saha I, Barua JK. Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from Eastern India. Indian J Dermatol. 2012;57(3):201-5.

Sameem F, Hassan I, Masood Q, Khan D, Majeed I, Kamili MA, et al. Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proportion? A study from Kashmir. Indian J Dermatol. 2010;55(4):355-8.

Hill CL, Zhang Y, Sigurgeirs B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatology and polymyositis: a population based study. Lancet. 2001;357(9250):96-100.

Ergun T, Inanc N, Tuney D, Kotilogu EK, Seckin D, Tetik C, et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. Int J Dermatol. 2008;47(9):894-902.

Hata T, Kavanaugh A. Rheumatoid arthritis in dermatology. Clin Dermatol. 2006;24(5):430-7.

Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, et al. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systemic review of the literature. J Eur Acad Dermatol Venerol. 2010;24(2):31-5.

Yang Q, Qu L, Tian H, Hu Y, Peng J, Yu X, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25(12):1409-14.

Rather S, Nisa N, Arif T. The pattern of psoriatic arthritis in kashmir: a 6-year prospective study. N Am J Med Sci. 2015;7(8):356-61.

McGonagle D, Tan AL, Benjamin M. The nail as a musculoskeletal appendage-implications for an improved understanding of the link between psoriasis and arthritis. Dermatology. 2009;218(2):97-102.

Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behcets disease in the north of Israel. Clin Rheumatol. 2007;26(4):555-60.

Lee S, Bang D, Lee E, Sohn S. Behcets disease: a guide to its clinical understanding. New York: Springer-Velag; 2001.

Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butan B. Review of the chronology of clinical manifestations in 60 patients with Behcets disease. Dermatology. 2003;207(4):354-6.

Saudoun D, Wechsler B, Desseaux K, Huong D, Amoura Z, Resche-Rigon M, et al. Mortality in Behcets disease. Arthritid Rheum. 2010;62(9):2806-12.

Xu LY, Esparza EM, Anadkat MJ, Crone KG, Brasington RD. Cutaneous manifestations of vasculitis. Semin Arthritis Rheum. 2009;38(5):348-60.

Younger DS, Carlson A. Dermatologic aspects of systemic vasculitis. Neurol Clin. 2019;37(2):465-73.

Loricera J, Calvo-Rio V, Mata C, Ortiz- Sanjuan F, Gonzalez-Lopez MA, Alvarez L, et al. Urticarial vasculitis in northern Spain. Clinical study of 21 cases. Medicine (Baltimore). 2014;93(1):53-60.

Downloads

Published

2023-04-27

Issue

Section

Original Research Articles